A study conducted by Dr. Nicolas Hulscher at the Wellness Company examined the effects of compounded Ivermectin and Menebedazole on 197 cancer patients over six months. While results appear promising, concerns arise regarding the study’s methodology, raising questions about the necessity of formal clinical trials for FDA consideration.
The Wellness Company Study of Ivermectin and Mebendazole Review
